Survival prediction model for patients with mycosis fungoides/Sezary syndrome

被引:1
|
作者
Zhu, Linlin [1 ]
Han, Xiaoyang [2 ]
Liu, Zhiwen [3 ]
Leng, Songze [1 ]
Shan, Ningning [4 ]
Lv, Xiao [4 ]
Lu, Kang [4 ]
Hun, Shouyong [5 ]
Wu, Yinhang [6 ]
Liu, Xin [4 ]
机构
[1] Shandong First Med Univ, Shandong Prov Hosp, Dept Hematol, Jinan, Shandong, Peoples R China
[2] Shandong Univ, Dept Radiat Oncol, Shandong Prov Hosp, Cheeloo Coll Med, Jinan, Shandong, Peoples R China
[3] Nanchang Univ, Affiliated Hosp 2, Dept Resp Med, Nanchang, Jiangxi, Peoples R China
[4] Shandong First Med Univ, Shandong Prov Hosp, Dept Hematol, Jinan, Shandong, Peoples R China
[5] Shandong First Med Univ, Shandong Prov Hosp, Dept Blood Transfus, Jinan, Shandong, Peoples R China
[6] Shandong Univ, Cheeloo Coll Med, Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Shandong, Peoples R China
关键词
chemotherapy; mycosis fungoides; Sezary syndrome; nomogram; prediction model; prognosis; radiotherapy; risk stratification; SEER; surgery; survival; ELECTRON-BEAM THERAPY; T-CELL LYMPHOMA; PROGNOSTIC-FACTORS; INTERNATIONAL-SOCIETY; UNITED-STATES; CLASSIFICATION; NOMOGRAM; ORGANIZATION; PATTERNS;
D O I
10.2217/fon-2020-0502
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim:A nomogram was constructed to forecast the overall survival (OS) of patients with mycosis fungoides/Sezary syndrome.Patients & Methods:The clinicopathological information of patients was obtained from the Surveillance, Epidemiology, and End Results (SEER) database. A model was established based on the independent prognostic factors. Predictive ability of the model was evaluated with the concordance index and calibration curves. Risk stratification was conducted for patients with similar tumor node metastasis (TNM) stages.Results:The model included 1997 eligible patients and seven prognostic factors for OS. The concordance index of the nomogram was 0.84 in the training and external validation cohorts, which indicated good predictive ability of the model and reliability of the results. The high agreement between the model predictions and actual observations was identified by calibration curves, which demonstrated the prediction accuracy of the model. Risk stratification displayed significant differences for patients with similar TNM stages, which suggested that the OS of patients with similar TNM stages could be further distinguished.Conclusion:We established a reliable nomogram to predict the OS of patients with mycosis fungoides/Sezary syndrome, which highlighted the advantages of nomograms over the conventional TNM staging system and promoted the application of individualized therapeutic strategies.
引用
收藏
页码:2487 / 2498
页数:12
相关论文
共 50 条
  • [1] Mycosis fungoides and Sezary syndrome
    Costello, Regis
    Farnault, Laure
    Bonnet, Nathalie
    Le Treut, Therese
    Poullin, Pascale
    Kahn-Perles, Brigitte
    HEMATOLOGIE, 2011, 17 (06): : 411 - 421
  • [2] Mycosis fungoides and Sezary syndrome
    Diamandidou, E
    Cohen, PR
    Kurzrock, R
    BLOOD, 1996, 88 (07) : 2385 - 2409
  • [3] Mycosis fungoides and the Sezary syndrome
    Foss, F
    CURRENT OPINION IN ONCOLOGY, 2004, 16 (05) : 421 - 428
  • [4] Mycosis fungoides and Sezary syndrome
    Hwang, Sam T.
    Janik, John E.
    Jaffe, Elaine S.
    Wilson, Wyndham H.
    LANCET, 2008, 371 (9616): : 945 - 957
  • [5] Mycosis fungoides and the Sezary syndrome
    Kim, YH
    Hoppe, RT
    SEMINARS IN ONCOLOGY, 1999, 26 (03) : 276 - 289
  • [6] Mycosis fungoides and Sezary syndrome
    Lee, Hyewon
    BLOOD RESEARCH, 2023, 58 : 66 - 82
  • [7] MYCOSIS FUNGOIDES - SEZARY SYNDROME
    ROENIGK, HH
    TAYLOR, JG
    ARCHIVES OF DERMATOLOGY, 1970, 101 (02) : 244 - &
  • [8] Mycosis Fungoides and Sezary Syndrome
    Foss, Francine M.
    Girardi, Michael
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (02) : 297 - +
  • [9] Mycosis fungoides and Sezary syndrome
    Jonak, Constanze
    Tittes, Julia
    Brunner, Patrick Manfred
    Guenova, Emmanuella
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 (09): : 1307 - 1332
  • [10] Alemtuzumab in patients with advanced mycosis fungoides and Sezary syndrome
    Beltran-Garate, Brady
    Gomez, Henry
    Lopez, Jose L.
    Borrego, Mildred
    Prieto, Mercedes
    Carrasco-Yalan, Antonio A.
    Huamani, Julia
    Castillo, Jorge
    Da Costa, Osiris
    BLOOD, 2007, 110 (11) : 1003A - 1004A